Research and development
Flow – sum over the period · $M
FY2020
28$M
All values (7)
| Period | Value ($M) | Status |
|---|---|---|
| FY2026 | 279 | reported |
| FY2025 | 147 | reported |
| FY2024 | 96 | reported |
| FY2023 | 77 | reported |
| FY2022 | 48 | reported |
| FY2021 | 35 | reported |
| FY2020 | 28 | reported |
| FY2016 – FY2019 | – | missing (4 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: rnd
More metrics for Credo
Income statement
Balance sheet
Sources & calculation
- Value
- $28.0M
- Period
- FY2020, ended Apr 30, 2020 · fiscal-year value (12 months)
- Source
- 10-K, filed Jun 8, 2022 · 0001628280-22-016593
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $28.0M | Jun 8, 2022 | 10-K 0001628280-22-016593 | reported · confidence 1. · current |